Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. Ribociclib is a kinase inhibitor. It was developed by Novartis and Astex Pharmaceuticals. From Wikipedia
Jackson reveals she has less than three years to live and reflects on her life and future hopes.
